Haemonetics Corporation

HAE·NYSE·$66.84Share Price as of 11/2·$3BMarket Cap as of 11/2

Financials

10-QQ1 ended 06/27/2608/06/26 10-KFY 202605/20/26 10-QQ3 ended 12/27/2502/05/26 10-QQ2 ended 09/27/2511/06/25 10-QQ1 ended 06/28/2508/07/25

Disclosures

8-KCurrent report10/08/26 8-KCurrent report08/18/26 8-KCurrent report08/06/26 8-KCurrent report07/28/26 8-KCurrent report06/05/26

Prospectuses and Registrations

S-8Registration of securities for employees08/06/26 S-8Registration of securities for employees08/11/23 POS AMPost-effective amendment07/30/19 S-8Registration of securities for employees07/30/19 S-8Registration of securities for employees02/05/18

Proxies

DEF 14ADefinitive proxy06/09/26 DEFA14AAdditional proxy materials06/09/26 DEF 14ADefinitive proxy06/06/25 DEFA14AAdditional proxy materials06/06/25 DEF 14ADefinitive proxy06/07/24

Ownership

SC 13G/ABeneficial ownership (amended)08/12/26 Form 3Initial insider ownership07/28/26 Form 4Insider transaction07/28/26 Form 4Insider transaction07/28/26 Form 4Insider transaction07/28/26

Other

ARSAnnual report to shareholders06/09/26 SDConflict Minerals disclosure05/28/26 ARSAnnual report to shareholders06/06/25 SDConflict Minerals disclosure05/27/25 ARSAnnual report to shareholders06/07/24